B. Riley Wealth Advisors Inc. Purchases New Shares in CME Group Inc. $CME

B. Riley Wealth Advisors Inc. acquired a new stake in CME Group Inc. (NASDAQ:CME) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 3,835 shares of the financial services provider’s stock, valued at approximately $1,057,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Webster Bank N. A. grew its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC lifted its position in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the period. Sagard Holdings Management Inc. acquired a new stake in shares of CME Group during the 2nd quarter worth $30,000. Ransom Advisory Ltd bought a new position in shares of CME Group in the first quarter worth $31,000. Finally, Trifecta Capital Advisors LLC increased its position in shares of CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $272.18 on Tuesday. The stock has a market capitalization of $98.15 billion, a price-to-earnings ratio of 26.37, a PEG ratio of 4.08 and a beta of 0.28. CME Group Inc. has a 52-week low of $224.62 and a 52-week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50 day moving average price is $272.06 and its two-hundred day moving average price is $272.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.68 EPS. On average, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.

Analysts Set New Price Targets

A number of research analysts have recently commented on CME shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Bank of America raised their target price on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Argus lowered their price target on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. TD Cowen raised their price objective on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, October 23rd. Finally, Royal Bank Of Canada upped their target price on CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a report on Friday, December 5th. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $290.00.

Insider Transactions at CME Group

In other news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This represents a 47.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 26,392 shares of company stock valued at $7,104,984. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.